Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10075-10087
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10075
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10075
n | Tumor | Chemotherapy regimen | Dosage of PLD | Cold therapy equipment | Cooling parts of the body | Cooling time | Incidence of HFS | Ref. |
20 | Ovarian cancer | Monotherapy | 30-50 mg/m2 | Ice packs | Around the wrists and ankles | After chemotherapy for 24 h | 1/17 (5.9%) | Molpus et al[12] |
53 | Ovarian cancer | Combination or monotherapy | 30-50 mg/m2 | Ice packs | Around the wrists and ankles | During chemotherapy infusion | 2/28 (7.1%) | Mangili et al[13] |
55 | Ovarian cancer | Combination | 30 mg/m2 | FGS | Whole hands and feet | From 15 min before infusion to 15 min after infusion | ≥ Grade 2 (31.70%) | Bun et al[14] |
41 | Monotherapy | 50 mg/m2 | ≥ Grade 2 (5.5%) | |||||
51 | Breast cancer | Combination | 30-35 mg/m2 | The cooling patches | Palm and back of hands | Start 15 min before infusion and lasted for 10 h | 1/51 (2.0%) | Our study |
- Citation: Zheng YF, Fu X, Wang XX, Sun XJ, He XD. Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients. World J Clin Cases 2021; 9(33): 10075-10087
- URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10075.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10075